Lymphatic Vascular Structures: A New Aspect in Proliferative Diabetic Retinopathy.

Area of Science:

• Ophthalmology
• Diabetology
• Vascular Biology

Background:

• Diabetic retinopathy (DR) is a major cause of blindness, stemming from diabetic microvascular complications.
• End-stage proliferative DR (PDR) involves complex ischemia, inflammation, neovascularization, and fibrosis.
• Current understanding of PDR pathogenesis is limited by sample and model availability, hindering therapeutic advancements.

Purpose of the Study:

• To deepen the molecular understanding of end-stage proliferative diabetic retinopathy (PDR).
• To explore novel findings in PDR, including lymphatic-like vessel formation and endothelial progenitor cell involvement.
• To identify pathways for improved evaluation, stratification, and treatment of PDR.

Main Methods:

• Utilized multidisciplinary approaches to study PDR.
• Developed novel ex vivo models for comprehensive molecular, cellular, and tissue-level analysis.
• Investigated recent findings on lymphatic-like vessels and progenitor cells in PDR neovascularization.

Main Results:

• Identified lymphatic-like vessel formation as a novel feature in PDR.
• Highlighted the role of abnormal endothelial differentiation and progenitor cells in PDR neovascularization.
• Established new ex vivo models for advanced PDR research.

Conclusions:

• A comprehensive understanding of PDR pathogenesis is critical for improving patient outcomes.
• Novel findings offer potential targets for enhanced DR therapies.
• Multidisciplinary approaches and new models are essential for advancing PDR research and treatment.